2011 Annual Meeting | Future of Neuroscience Conference: Implications of the Alzheimer's Disease Neuroimaging Initiative (ADNI) for Treatment

Date Friday 04/15/11

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuroscience Conference

Director(s) Ronald C. Petersen, MD, PhD, FAAN

Topic(s) Aging and Dementia

Learning Objectives Participants should be able to appreciate the current and potential utility of neuroimaging and biomarkers in classifying patients across the spectrum from normal cognition, MCI, to Alzheimer’s disease.

CME Available No CME available

Core Competencies Medical Knowledge

Recommended Audience Other, Specialist Neurologist

Teaching Styles Didactic, Interactive

Event Timeline
09:00 AM - 09:15 AM		Introduction Ronald C. Petersen, MD, PhD, FAAN
09:00 AM - 05:00 PM	Abstract	001 - Localized Hippocampus Markers Change Earlier in the Alzheimer Pathological Process Than Total Hippocampus Volume Does
09:00 AM - 05:00 PM	Abstract	001 - FDG-PET in Evaluating Mild Cognitive Probelms in a Clinical Population
09:00 AM - 05:00 PM	Abstract	002 - [beta]-Amyloid Deposition, [sup]1[/sup]H MRS Metabolites and Cognitive Function in a Population-Based Cohort of Cognitively Normal Elderly
09:00 AM - 05:00 PM	Abstract	002 - Serial Memory Decline in [ldquo]Healthy[rdquo] Community Volunteers Predicts Amyloid Accumulation
09:00 AM - 05:00 PM	Abstract	003 - Automated Diagnostic Classifiers for Cognitively Normal and Mild Cognitive Impairment Subjects Using Imaging, Genotyping, and Gene Expression
09:00 AM - 05:00 PM	Abstract	003 - Value of Neuropsychological Testing, Imaging and CSF Biomarkers for the Differential Diagnosis of Clinically Ambiguous Dementia
09:00 AM - 05:00 PM	Abstract	004 - Florbetapir F 18 PET Imaging and CSF Biomarkers Provide Concordant Measures of Underlying Brain Amyloid Pathology and Cognitive Performance
09:00 AM - 05:00 PM	Abstract	004 - Brain Volume Decline Predicts Cognitive Decline: The AGES Reykjavik Study
09:00 AM - 05:00 PM	Abstract	005 - Alzheimer-Signature MRI Biomarker Predicts AD Dementia in Cognitively Normal Adults
09:00 AM - 05:00 PM	Abstract	005 - Comparison of Amyloid Imaging and FDG PET in Pathologically Verified Dementia
09:00 AM - 05:00 PM	Abstract	006 - Operationalization of Differences among Protocols for Manual Hippocampal Segmentation: Quantitative Data for EADC-ADNI Consensual Decisions on a Harmonized Protocol
09:00 AM - 05:00 PM	Abstract	007 - [sup]18[/sup]F-Flutemetamol Amyloid Imaging Has Strong Concordance with Cortical Biopsy Histopathology
09:00 AM - 05:00 PM	Abstract	008 - Maternal Family History of Alzheimer[apos]s Disease Predisposes to Increased Cortical Atrophy; an ADNI Study
09:00 AM - 05:00 PM	Abstract	009 - Natural History of Cortical Amyloid Deposition in Alzheimer[apos]s Disease Associated with PIB PET Imaging
09:00 AM - 05:00 PM	Abstract	010 - Clinical Predictors of Severe Cerebral Amyloid Angiopathy in Alzheimer[apos]s Disease Patients
09:00 AM - 05:00 PM	Abstract	011 - Resting State Connectivity in Posterior Cingulate and Hyppocampus in Mild Alzheimer[apos]s Disease and Mild Cognitive Impairment
09:00 AM - 05:00 PM	Abstract	012 - Hyperphosphorylated Tau Protein and [beta]-Amyloid in the Cerebrospinal Fluid of Patients with Alzheimer[apos]s Disease and Depression. Preliminary Findings
09:00 AM - 05:00 PM	Abstract	013 - Effect of Microbleeds on Cognition in PIB-Negative Subcortical Vascular Cognitive Impairment
09:00 AM - 05:00 PM	Abstract	014 - Functional Connectivity, Structural Brain and Cognitive Performance in Elderly
09:15 AM - 10:00 AM		Clinical Core Considerations Ronald C. Petersen, MD, PhD, FAAN
10:00 AM - 10:45 AM		Break and Posters
10:45 AM - 11:15 AM		Abstract Presentations
11:15 AM - 12:00 PM		Candidate Genes, Pathways, and GWAS of Quantitative ADNI Phenotypes Andrew J. Saykin, PsyD
12:00 PM - 01:00 PM		Luncheon
01:00 PM - 01:45 PM		What Have We Learnt in the ADNI Study Charles S. DeCarli, MD, FAAN
01:45 PM - 02:30 PM		PET Imaging Using FDG and Amyloid Tracers Norman L. Foster, MD, FAAN
02:30 PM - 03:15 PM		Break and Posters
03:15 PM - 04:00 PM		Abstract Presentations
04:00 PM - 04:45 PM		Biomarkers in the CSF and Blood Douglas Galasko, MD
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Christopher Clark, MD	No disclosure on file
Jeffrey L. Cummings, MD, FAAN	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. DeCarli has received research support from NIH.
Norman L. Foster, MD, FAAN	No disclosure on file
Douglas Galasko, MD	Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Galasko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for vTv Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. Galasko has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BioMed Central.
John M. Hoffman, MD	No disclosure on file
Bradley T. Hyman, MD, PhD	An immediate family member of Dr. Hyman has received personal compensation for serving as an employee of novartis. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for dewpoint. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Hyman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for avrobio. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dept of Justice. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cell Signalling. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Hyman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for sanofi. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vigil. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for voyager. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for dept of justice. Dr. Hyman has stock in dewpoint. The institution of Dr. Hyman has received research support from nih. The institution of Dr. Hyman has received research support from JPB. The institution of Dr. Hyman has received research support from Cure Alz Fund. The institution of Dr. Hyman has received research support from Tau consortium. The institution of Dr. Hyman has received research support from abbvie. The institution of Dr. Hyman has received research support from BMS.
William Jagust, MD	No disclosure on file
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Bruce L. Miller, MD, FAAN	Dr. Miller has nothing to disclose.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Michael L. Swerdlow, MD	Dr. Swerdlow has nothing to disclose.
Craig E. Watson, MD, PhD, FAAN	No disclosure on file
Edward Y. Zamrini, MD	Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH.
Andrew J. Saykin, PsyD	Dr. Saykin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Oncology. Dr. Saykin has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature Publishing. The institution of Dr. Saykin has received research support from Eli Lilly/Avid Radiopharmaceuticals.
Steven E. Arnold, MD	Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EIP Pharma. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Boyle Shaughnessy Law. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wolf Greenfield. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Bob's Last Marathon.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Christopher Rowe, MD	Dr. Rowe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rowe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Rowe has received research support from Cerveau Technologies. The institution of Dr. Rowe has received research support from Eisai. The institution of Dr. Rowe has received research support from Biogen.
Richard M. Camicioli, MD, FAAN	No disclosure on file
Hilkka S. Soininen, MD, PhD	Dr. Soininen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk.
Reisa A. Sperling, MD	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nervgen. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oligomerix. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vaxxinity. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. An immediate family member of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Sperling has received research support from Eli Lilly. The institution of Dr. Sperling has received research support from Eisai. The institution of Dr. Sperling has received research support from NIH.
Michael J. Pontecorvo, PhD	Dr. Pontecorvo has received personal compensation for serving as an employee of Eli Lilly. Dr. Pontecorvo has stock in Eli Lilly.
Maryam R. Beigi, MD	No disclosure on file
Duk L. Na, MD	No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Russell H. Swerdlow, MD	No disclosure on file
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Giovanni B. Frisoni, MD	No disclosure on file
David Darby, MBBS, PhD, FRACP	No disclosure on file
Jae-Hong Lee, MD	No disclosure on file
Lenore J. Launer, PhD	No disclosure on file
Howard J. Rosen, MD	Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. The institution of Dr. Rosen has received research support from NIH. The institution of Dr. Rosen has received research support from State of CA. Dr. Rosen has a non-compensated relationship as a Consultant with Alector that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a Consultant with Prevail Therapeutics that is relevant to AAN interests or activities. Dr. Rosen has a non-compensated relationship as a consultant with Alchemab that is relevant to AAN interests or activities.
Gioacchino Tedeschi, MD	Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
John M. Ringman, MD, FAAN	The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
David A. Wolk, MD, FAAN	Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly.
Martine Vercelletto, MD	No disclosure on file
George Bartzokis, MD	No disclosure on file
Bruce R. Reed, PhD	No disclosure on file
Ronald J. Killiany, PhD	Dr. Killiany has nothing to disclose.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Martin A. Nogues	No disclosure on file
John Q. Trojanowski, MD, PhD	Dr. Trojanowski has nothing to disclose.
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN	Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities.
Dan M. Mungas, PhD	Dr. Mungas has nothing to disclose.
Jeffrey M. Burns, MD	Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Robert J. Ivnik, PhD	No disclosure on file
Gena R. Ghearing, MD	The institution of Dr. Ghearing has received research support from Center for Disease Control and Prevention.
Paul M. Thompson, PhD	No disclosure on file
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
William W. Seeley, MD	Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Liana Apostolova, MD, FAAN	Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. An immediate family member of Dr. Apostolova has stock in Cassava Neurosciences. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging.
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Marina Boccardi, PhD	No disclosure on file
Gil D. Rabinovici, MD, FAAN	Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Rabinovici has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Norodisk. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Consultant for C2N. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Joihnson. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Peerview. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Rabinovici has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. The institution of Dr. Rabinovici has received research support from NIH. The institution of Dr. Rabinovici has received research support from American College of Radiology. The institution of Dr. Rabinovici has received research support from Alzheimer's Association. The institution of Dr. Rabinovici has received research support from Rainwater Charitable Foundation. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Topic Chair, Course Director and teacher with AAN. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH. Dr. Rabinovici has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with ANA.
	No disclosure on file
Kejal Kantarci, MD	The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF.
Eric Huang, MD	No disclosure on file
Rebecca Spain, MD, MSPH, FAAN	Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Richard D. King, MD, PhD, FAAN	Dr. King has nothing to disclose.
Po-Haong Lu	No disclosure on file
Rosebud O. Roberts, MD	No disclosure on file
Marilyn Albert	Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health.
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Owen T. Carmichael, PhD	No disclosure on file
Alexandra Urban, MD, FAAN	Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science, Inc. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Mark A. Mintun, MD	Dr. Mintun has received personal compensation for serving as an employee of Eli Lilly & Co.
Paul Maruff, PhD	Dr. Maruff has received personal compensation for serving as an employee of Cogstate .
Sook-Hui Kim, MD	No disclosure on file
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Sangwon Seo, MD	No disclosure on file
Claire Boutoleau-Bretonniere, MD	No disclosure on file
Jaesung Kim, MD	No disclosure on file
Daniel Skovronsky, MD, PhD	No disclosure on file
Jing He	No disclosure on file
Robyn Honea, PhD	No disclosure on file
Kristy Hwang	No disclosure on file
Jean-Sebastien Vidal	No disclosure on file
Shizuo Hatashita, MD, PhD	No disclosure on file
Manuela De Stefano	No disclosure on file
Emily Johnson, MD	Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiWatch. The institution of Dr. Johnson has received research support from NIH.
Simon Duchesne, PhD	Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care.
Eric Vidoni, PhD, PT	No disclosure on file
Amy Brodtmann, MBBS, PhD, FRACP	Prof. Brodtmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Brodtmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Prof. Brodtmann has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. The institution of Prof. Brodtmann has received research support from National Health and Medical Research Council. The institution of Prof. Brodtmann has received research support from Medical Research Future Fund. The institution of Prof. Brodtmann has received research support from National Heart Foundation. The institution of Prof. Brodtmann has received research support from Victorian Medical Research Acceleration Fund. Prof. Brodtmann has a non-compensated relationship as a Honorary Medical Advisor with Dementia Australia that is relevant to AAN interests or activities.
Taylor Da Silva Junior, MD	No disclosure on file
Igor Grachev	No disclosure on file
Jae Hyun Park, MD	No disclosure on file
Nicholas J. Lanciano, DO	No disclosure on file
Kunal V. Desai, MD	Dr. Desai has nothing to disclose.
Bridget A. Leone, MD	Dr. Leone has nothing to disclose.
Mariana G. Santos, MD	No disclosure on file
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Krithiga Sekar, MD, PhD	No disclosure on file
Han-kyeol Kim	No disclosure on file
Jessica Kiarashi, MD	Dr. Kiarashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for COVE.
Stephen Weigand	Stephen Weigand has nothing to disclose.
Scott Przybelski	Scott Przybelski has nothing to disclose.
Harry Vinters	No disclosure on file

��ɫ��

��ɫ��